Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-12-22
1998-11-24
Woodward, Michael P.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530326, 5303895, 4241851, 4241901, 4242481, C07K 1612, C07K 708, A61K 3904
Patent
active
058408550
ABSTRACT:
Recombinant 540 amino acid residue and 517 amino acid residue proteins encoded by the genome of Mycobacterium tuberculosis are disclosed as are vectors for propagating their DNA sequences and expressing the proteins. Also disclosed are methods for using those proteins. Peptides that correspond substantially to the sequences of those proteins and methods of their use are also disclosed, as are polymers containing peptide repeating units corresponding to the 540 residue protein and also polymers containing 517 protein pentapeptides as repeating units.
REFERENCES:
patent: 4769237 (1988-09-01), Bittle et al.
patent: 4906742 (1990-03-01), Young et al.
P-S Juo, Concise Dictionary Biomedicine and Molecular Biology, CRC Press, Boca Raton (1996) pp. 486 and 688.
J. M. Cruse and R. E. Lewis, Illustrated Dictionary of Immunology, CRS Press, Boca Raton (1995) pp. 163 and 228.
P. Singleton and D. Sainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed. Wiley-Interscience, New York (1993) pp. 447 and 637.
Trends In Microbiology, 3(10), (Oct. 1995) Cover and Content pages.
Orme, Trends in Microbiology, 1(3): 77-78 (Jun. 1993).
Silva et al., Infect Immun., 64(7):2400-2407 (Jul. 1996).
Tascon et al., Nature Medicine, 2(8): 888-892 (Aug. 1996).
Orme, "Prospects For New Vaccines Against Tuberculosis," Trends in Microbiol 3:401-404 (1995).
Roche et al., "BCG Vaccination Against Tuberculosis: Past Disappointments," Trends in Microbiology 3:397-401 (1995).
Atassi et al., Antigen-Specific T Cell Receptors and Factors, 37-51 + 55-63 (1987).
Sela, Adv. Immunol., 5:115-117 (1966).
Laver et al., Current Communications in Molecular Biology, Immune Recognition of Protein Antigens, Cold Spring Harbor Lab., N.Y. pp. 71-76; 156-160.
Francis et al., Vaccines 88, Ginsberg et al., eds., Cold Spring Harbor Lab., N.Y. pp. 1-7 (1988).
Francis et al., Vaccines 87, Chanock et al., eds., Cold Spring Harbor Lab., N.Y. pp. 60-67 (1987).
Germain, R.N., Nature, 322:687-689 (1986).
Schwartz, R.H., Nature, 326:738-739 (1987).
Young et al., Proc. Natl. Acad. Sci., USA, 82:2583-2587 (1985).
Spouge et al., J. Immunol., 138:204-212 (1987).
Berzofsky, J.A., Science, 229:932-940 (1985).
DeLisi et al., Proc. Natl. Acad. Sci., USA, 82, 7048-7052 (1985).
Fatham et al., Ann. Rev. Immunol., 1:633-655 (1985).
General Index p. 392, title and copyright pages of the ATCC catalogue of Cell Lines and Hybridomas for 1988.
Bittle et al., Nature, 298:30-33 (Jul. 1982).
Finnegan et al., J. Exp. Med., 164:897-910 (1986).
Shinnick et al., Infect Immun., 55:1932-1935 (Aug. 1987).
Gillis et al., Infect Immun., 37:172-178 (1982).
Gillis et al., Infect Immun., 49:371-377 (1985).
Mustafa, et al., Lepr. Rev., 57,Suppl. 2:123-130 (1986).
Thole et al., Infect. Immun., 50:800-806 (1985).
Emmerich et al., J. Exp. Med., 163:1024-1029 (1986).
Mehra et al., Proc. Natl. Acad. Sci., USA, 83:7013-7017 (1986).
Engers (Rapporteur), Infect Immun., 51:718-720 (1986).
Young et al., Nature, 316:450-452 (1985).
Mustafa et al., Nature, 319:63-66 (1986).
Boom et al., Infect Immun., 55:2223-2229 (Sep. 1987).
Kaufmann et al., Eur J. Immunol., 17:351-357 (1987).
Melancon-Kaplan et al., Proc. Natl. Acad. Sci., USA, 85:1917-1921 (Mar. 1988).
Lu et al., Infect Immun., 55:2378-2382 (Oct. 1987).
Kingston et al., Infect Immun., 55:3149-3154 (Dec. 1987).
Oftung et al., J. Immunol., 141:2749-2754 (1988).
Houghten Richard
Shinnick Thomas
Scripps Clinic and Research Foundation
Woodward Michael P.
LandOfFree
Mycobacterial recombinants and peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycobacterial recombinants and peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterial recombinants and peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1703544